FI914621A0 - Heterocykliska syror. - Google Patents
Heterocykliska syror.Info
- Publication number
- FI914621A0 FI914621A0 FI914621A FI914621A FI914621A0 FI 914621 A0 FI914621 A0 FI 914621A0 FI 914621 A FI914621 A FI 914621A FI 914621 A FI914621 A FI 914621A FI 914621 A0 FI914621 A0 FI 914621A0
- Authority
- FI
- Finland
- Prior art keywords
- thromboxane
- formula
- group
- alkyl
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909021571A GB9021571D0 (en) | 1990-10-04 | 1990-10-04 | Heterocyclic acids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI914621A0 true FI914621A0 (fi) | 1991-10-02 |
| FI914621A FI914621A (fi) | 1992-04-05 |
Family
ID=10683219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI914621A FI914621A (fi) | 1990-10-04 | 1991-10-02 | Heterocykliska syror. |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US5219874A (fi) |
| EP (1) | EP0482771B1 (fi) |
| JP (1) | JPH04273871A (fi) |
| KR (1) | KR100191763B1 (fi) |
| AT (1) | ATE154603T1 (fi) |
| AU (1) | AU646493B2 (fi) |
| CA (1) | CA2052294A1 (fi) |
| DE (1) | DE69126593T2 (fi) |
| DK (1) | DK0482771T3 (fi) |
| ES (1) | ES2103301T3 (fi) |
| FI (1) | FI914621A (fi) |
| GB (2) | GB9021571D0 (fi) |
| GR (1) | GR3023804T3 (fi) |
| IE (1) | IE913111A1 (fi) |
| IL (1) | IL99441A (fi) |
| NO (1) | NO303781B1 (fi) |
| NZ (1) | NZ239698A (fi) |
| PT (1) | PT99153B (fi) |
| ZA (1) | ZA917066B (fi) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5248780A (en) * | 1988-02-16 | 1993-09-28 | Imperial Chemical Industries, Plc | Pyridyl substituted alkenoic acid derivatives |
| CA2179168A1 (en) * | 1993-12-17 | 1995-06-22 | Douglas A. Kniss | Antisense oligonucleotides to suppress eicosanoid formation |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58150575A (ja) * | 1982-03-04 | 1983-09-07 | Chugai Pharmaceut Co Ltd | 新規なプロスタグランジン誘導体 |
| GB8310407D0 (en) * | 1982-05-12 | 1983-05-25 | Ici Plc | 1 3 - dioxan -5- ylalkenoic acids |
| GB8330099D0 (en) * | 1983-11-11 | 1983-12-21 | Ici Plc | Cycloalkane derivatives |
| GB8330097D0 (en) * | 1983-11-11 | 1983-12-21 | Ici Plc | Cyclic ethers |
| GB8330120D0 (en) * | 1983-11-11 | 1983-12-21 | Ici Plc | Chemical process |
| GB8330094D0 (en) * | 1983-11-11 | 1983-12-21 | Ici Plc | Diphenyl compounds |
| GB8511890D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Benzene derivatives |
| GB8511891D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Alkenoic acids |
| GB8511892D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Fluoralkane derivatives |
| GB8511894D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Phenol derivatives |
| HU198706B (en) * | 1985-05-10 | 1989-11-28 | Ici Plc | Process for producing 1,3-dioxan-ethers and pharmaceutical compositions containing them |
| ES8802508A1 (es) * | 1985-05-10 | 1988-07-16 | Ici Plc | Procedimiento para preparar derivados alquenicos. |
| GB8511895D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Heterocyclic compounds |
| WO1987002983A1 (en) * | 1985-11-12 | 1987-05-21 | Imperial Chemical Industries Plc | Amide derivatives |
| GB8611174D0 (en) * | 1986-05-08 | 1986-06-18 | Ici Plc | Amide derivatives |
| GB8531892D0 (en) * | 1985-12-30 | 1986-02-05 | Ici Plc | Carboxylic acids |
| GB8626296D0 (en) * | 1986-11-04 | 1986-12-03 | Ici Plc | Therapeutic agents |
| GB8626297D0 (en) * | 1986-11-04 | 1986-12-03 | Ici Plc | Pharmaceutical compositions |
| GB8709794D0 (en) * | 1987-04-24 | 1987-05-28 | Ici Plc | Heterocyclic acids |
| GB8901201D0 (en) * | 1988-02-16 | 1989-03-15 | Ici Plc | Pyridine derivatives |
| EP0346511A1 (en) * | 1988-06-15 | 1989-12-20 | Fujisawa Pharmaceutical Co., Ltd. | Oxygen-containing hererocyclic compound, processes for their preparation and pharmaceutical compositions comprising them |
| GB8814340D0 (en) * | 1988-06-16 | 1988-07-20 | Ici Plc | Process |
| IE81170B1 (en) * | 1988-10-21 | 2000-05-31 | Zeneca Ltd | Pyridine derivatives |
| AU6307690A (en) * | 1989-09-27 | 1991-04-11 | Rhone-Poulenc Sante | Imidazoles |
| KR910006904B1 (ko) * | 1989-10-16 | 1991-09-10 | 한국과학기술연구원 | 새로운 에스테르 화합물 및 그의 제조방법 |
-
1990
- 1990-10-04 GB GB909021571A patent/GB9021571D0/en active Pending
-
1991
- 1991-09-02 GB GB919118729A patent/GB9118729D0/en active Pending
- 1991-09-04 IE IE311191A patent/IE913111A1/en unknown
- 1991-09-05 ZA ZA917066A patent/ZA917066B/xx unknown
- 1991-09-06 NZ NZ239698A patent/NZ239698A/en unknown
- 1991-09-08 IL IL9944191A patent/IL99441A/en not_active IP Right Cessation
- 1991-09-09 AU AU83727/91A patent/AU646493B2/en not_active Ceased
- 1991-09-20 US US07/763,304 patent/US5219874A/en not_active Expired - Fee Related
- 1991-09-26 ES ES91308805T patent/ES2103301T3/es not_active Expired - Lifetime
- 1991-09-26 DK DK91308805.0T patent/DK0482771T3/da active
- 1991-09-26 DE DE69126593T patent/DE69126593T2/de not_active Expired - Fee Related
- 1991-09-26 EP EP91308805A patent/EP0482771B1/en not_active Expired - Lifetime
- 1991-09-26 CA CA002052294A patent/CA2052294A1/en not_active Abandoned
- 1991-09-26 AT AT91308805T patent/ATE154603T1/de not_active IP Right Cessation
- 1991-10-02 KR KR1019910017387A patent/KR100191763B1/ko not_active IP Right Cessation
- 1991-10-02 FI FI914621A patent/FI914621A/fi unknown
- 1991-10-03 PT PT99153A patent/PT99153B/pt not_active IP Right Cessation
- 1991-10-03 NO NO913886A patent/NO303781B1/no not_active IP Right Cessation
- 1991-10-04 JP JP3257669A patent/JPH04273871A/ja active Pending
-
1993
- 1993-03-24 US US08/036,304 patent/US5410064A/en not_active Expired - Fee Related
-
1997
- 1997-06-19 GR GR970401343T patent/GR3023804T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69126593D1 (de) | 1997-07-24 |
| GB9021571D0 (en) | 1990-11-21 |
| US5410064A (en) | 1995-04-25 |
| GR3023804T3 (en) | 1997-09-30 |
| FI914621A (fi) | 1992-04-05 |
| GB9118729D0 (en) | 1991-10-16 |
| ES2103301T3 (es) | 1997-09-16 |
| IL99441A (en) | 1996-12-05 |
| DK0482771T3 (da) | 1998-01-26 |
| AU8372791A (en) | 1993-03-18 |
| KR920008022A (ko) | 1992-05-27 |
| JPH04273871A (ja) | 1992-09-30 |
| US5219874A (en) | 1993-06-15 |
| KR100191763B1 (ko) | 1999-06-15 |
| EP0482771B1 (en) | 1997-06-18 |
| NO913886D0 (no) | 1991-10-03 |
| EP0482771A2 (en) | 1992-04-29 |
| IE913111A1 (en) | 1992-04-08 |
| ZA917066B (en) | 1992-06-24 |
| EP0482771A3 (en) | 1992-07-01 |
| PT99153A (pt) | 1992-09-30 |
| AU646493B2 (en) | 1994-02-24 |
| ATE154603T1 (de) | 1997-07-15 |
| DE69126593T2 (de) | 1997-10-02 |
| NZ239698A (en) | 1994-03-25 |
| CA2052294A1 (en) | 1992-04-05 |
| IL99441A0 (en) | 1992-08-18 |
| NO913886L (no) | 1992-04-06 |
| PT99153B (pt) | 1999-04-30 |
| NO303781B1 (no) | 1998-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE126216T1 (de) | Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung. | |
| KR860008173A (ko) | 치환된 n-[(4-피페리딘일)알킬]비사이클축합 옥사졸아민 및 티아졸아민의 제조방법 | |
| ATE259376T1 (de) | Heterozyklische verbindungen, ihre zwischenprodukte und elastase-inhibitoren | |
| AU6785201A (en) | Novel pyrazinone derivatives | |
| US20020198189A1 (en) | New use | |
| DK0780125T3 (da) | Anvendelse af hydantoinderivater til fremstilling af et lægemiddel til behandling af sygdomme associeret med tilstedeværelse af aktivt oxygen og frie radikaler | |
| FI882909A0 (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten furanyylimetyylisubstituoitujen bentsimidatsoli- ja imidatsopyridiinijohdannaisten valmistamiseksi | |
| KR930006024A (ko) | 이미다조 인돌리진 유도체 및 그의 제조방법 | |
| FI914621A0 (fi) | Heterocykliska syror. | |
| KR920009834A (ko) | 7-아실-3-(치환 카르바모일옥시)세펨 화합물 및 그의 제조 방법 | |
| KR940007008A (ko) | 1, 3, 4-벤조트리아제핀-5(4h)-온 유도체 및 이것의 제조 방법 | |
| NO872501L (no) | Fremgangsmte for fremstilling av terapeutisk aktive triazol- og imidazol-derivater. | |
| EA200200379A3 (ru) | Новые соединения пиримидин-4-она, способ их получения и содержащие их фармацевтические композиции |